You still fail to explain and proof your point that the "marketable securities" on the balance sheet of TenaxTherapeutics are in fact TENX shares "to be issued in the future".
Where are the $40 million gone? Don't you think TENX would need to announce a share buy back if that position (marketable securities) in the balance sheet would really be shares of their own company? simply because "to be issued shares" will never, ever appear as marketable securities in a balance sheet, period.
News 
Market Data 
Discover 
